Rare diseases
Investigational molecules
Locations
Study of Dostarlimab and Drug Combination for Patients with Untreated Resectable Colon Cancer
NorwayStudy of Pembrolizumab and Olaparib with Chemoradiation for Patients with Stage III Non-Small Cell Lung Cancer
NorwayStudy on the Safety and Effectiveness of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NorwayStudy of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma
NorwayStudy on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis
NorwayStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
NorwayStudy of Oxaliplatin and Nivolumab for Patients with Metastatic Colorectal Cancer
NorwayStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
NorwayStudy on the Safety and Effects of AZD4831 for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) with Fibrosis
NorwayStudy on the Effectiveness and Safety of UV1 Vaccine with or without Sargramostim for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
NorwayStudy of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma
NorwayStudy on Cyclophosphamide for Patients with Advanced Breast Cancer with TP53 Mutations
NorwayTell us about your condition – we search every trial in Europe and connect you with the right site.
